Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

The prognostic value of microvessel density (MVD) in head and neck squamous cell carcinoma (HNSCC) remains disputable. The purpose of this study was to comprehensively determine the prognostic value of MVD in HNSCC. Relevant literatures were identified using PubMed, Embase, and Cochrane Library. A m...

Full description

Bibliographic Details
Main Authors: Yanbo Dong, Guangzhi Ma, Yukun Liu, Siyu Lu, Liangfa Liu
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2020/8842795
id doaj-761a30b5067a48259b6c99693306c86f
record_format Article
spelling doaj-761a30b5067a48259b6c99693306c86f2020-11-25T02:41:58ZengHindawi LimitedDisease Markers0278-02401875-86302020-01-01202010.1155/2020/88427958842795Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-AnalysisYanbo Dong0Guangzhi Ma1Yukun Liu2Siyu Lu3Liangfa Liu4Department of Otolaryngology Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaDepartment of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, ChinaDepartment of Emergency, Aviation General Hospital, Beijing 100012, ChinaDepartment of Otolaryngology Head and Neck Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaThe prognostic value of microvessel density (MVD) in head and neck squamous cell carcinoma (HNSCC) remains disputable. The purpose of this study was to comprehensively determine the prognostic value of MVD in HNSCC. Relevant literatures were identified using PubMed, Embase, and Cochrane Library. A meta-analysis was performed to clarify the prognostic role of MVD in HNSCC patients and different subgroups. A total of 14 eligible articles were included in this meta-analysis. The combined hazard ratio (HR) and 95% confidence interval (95% CI) for overall survival (OS) of 11 studies was 1.663 (1.236-2.237, P=0.001), and the pooled HR and 95% CI for progression-free survival (PFS) of 7 studies was 2.069 (1.281-3.343, P=0.003). Subgroup analyses were also performed on different issues, such as regional distribution of patients, age, tumor location, antibody, and treatment strategy. To conclude, high MVD is associated with worse OS and PFS in patients with HNSCC.http://dx.doi.org/10.1155/2020/8842795
collection DOAJ
language English
format Article
sources DOAJ
author Yanbo Dong
Guangzhi Ma
Yukun Liu
Siyu Lu
Liangfa Liu
spellingShingle Yanbo Dong
Guangzhi Ma
Yukun Liu
Siyu Lu
Liangfa Liu
Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
Disease Markers
author_facet Yanbo Dong
Guangzhi Ma
Yukun Liu
Siyu Lu
Liangfa Liu
author_sort Yanbo Dong
title Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
title_short Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
title_full Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
title_fullStr Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
title_full_unstemmed Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
title_sort prognostic value of microvessel density in head and neck squamous cell carcinoma: a meta-analysis
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 2020-01-01
description The prognostic value of microvessel density (MVD) in head and neck squamous cell carcinoma (HNSCC) remains disputable. The purpose of this study was to comprehensively determine the prognostic value of MVD in HNSCC. Relevant literatures were identified using PubMed, Embase, and Cochrane Library. A meta-analysis was performed to clarify the prognostic role of MVD in HNSCC patients and different subgroups. A total of 14 eligible articles were included in this meta-analysis. The combined hazard ratio (HR) and 95% confidence interval (95% CI) for overall survival (OS) of 11 studies was 1.663 (1.236-2.237, P=0.001), and the pooled HR and 95% CI for progression-free survival (PFS) of 7 studies was 2.069 (1.281-3.343, P=0.003). Subgroup analyses were also performed on different issues, such as regional distribution of patients, age, tumor location, antibody, and treatment strategy. To conclude, high MVD is associated with worse OS and PFS in patients with HNSCC.
url http://dx.doi.org/10.1155/2020/8842795
work_keys_str_mv AT yanbodong prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis
AT guangzhima prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis
AT yukunliu prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis
AT siyulu prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis
AT liangfaliu prognosticvalueofmicrovesseldensityinheadandnecksquamouscellcarcinomaametaanalysis
_version_ 1715412344547311616